#USA #Natus Medical #Middleton #autoSCORE #EEG Analysis

Natus Medical Unveils autoSCORE AI Analysis Tool

Natus Medical Incorporated has announced a significant advancement in the field of neurodiagnostics with the global launch of the autoSCORE™ analysis tool. This revolutionary artificial intelligence model is designed to facilitate automatic and in-depth clinical interpretations of electroencephalograms (EEG), achieving a level of accuracy comparable to that of the world's leading medical experts.

The introduction of autoSCORE marks a notable pivot in how EEG studies are conducted, especially following its initial release in the U.S. market in August 2024. Natus has positioned itself as a pivotal player in neuro care, providing an innovative solution that eases the burden on clinical resources and staff. Developed by Holberg EEG in Norway, this deep-learning model was trained using over 30,000 expert-labeled EEG recordings, a feat that establishes its credibility and functionality.

CEO Chris Landon expressed his excitement for the autoSCORE tool, stating, "Developing the first AI model capable of interpreting clinical EEGs at the level of the world's top experts marks a defining moment for both Natus and the field of neurodiagnostics. By introducing this transformative technology, we aim to enhance patient access and produce life-changing outcomes through cutting-edge solutions."

The autoSCORE tool has received FDA 510(k) clearance for its expansive applications, which include routine EEG, long-term monitoring (LTM), and Ambulatory EEG studies. Furthermore, it has been awarded the CE mark, allowing it to reach markets across Europe and beyond.

Early adopters of this technology have expressed satisfaction with autoSCORE's ability to surpass conventional spike and seizure detectors. It assesses a variety of clinically relevant abnormalities while producing study-level evaluations that guide healthcare providers in determining whether EEG studies exhibit normal or abnormal results. This effective solution aims to alleviate the pressures usually associated with visual EEG reviews, known as the gold standard for identifying abnormalities but often taxing on department resources.

Dr. Ram Mohan Sankaraneni, a board-certified neurologist and part of the American Epilepsy Society and the American Academy of Neurology, has hailed the autoSCORE tool as a reliable partner in clinical decision-making. He stated, "Human teaming with intelligent machines has become a fundamental characteristic of a successful clinical decision support system. This tool is not just a piece of technology; it stands as a dependable colleague that offers a second opinion and provides a robust path towards swifter interventions."

The closed AI model of autoSCORE also provides consistency and security, principles that are crucial in the medical field where both accuracy and reliability are paramount. As healthcare continues to advance, Natus Medical's autoSCORE tool exemplifies the integration of technology and clinical expertise, paving the way for improved efficiency and outcomes in the neurodiagnostics landscape.

In summary, the launch of the autoSCORE analysis tool by Natus Medical signifies an important evolution in EEG analysis. With its commitment to enhancing healthcare delivery and its innovative approach, Natus is setting a new standard for neurodiagnostics that prioritizes both accuracy and efficiency for healthcare providers worldwide. For further insights into Natus’s offerings, one can visit their website at natus.com/neuro.